Abstract:Objective Objective To investigate the effects of harmine (HM) on the proliferation and apoptosis of NCTC1469 murine hepatic cells and PC12 neural cells in order to provide a reference for research and development of harmine derivatives as potential treatments for echinococcosis.Methods The NCTC1469 murine hepatic cells and PC12 neural cells cultured in vitro were divided into an HM treatment group and an untreated control group.An MTT assay was used to determine the inhibitory effect of different concentrations of HM on cell proliferation.Morphological changes in cells were observed under an inverted microscope.Morphological changes as a result of apoptosis were observed with Hoechst 33258 nuclear staining.Apoptosis was detected with flow cytometry (FCM).Results The MTT assay indicated that proliferation of both PC12 and NCTC1469 cells was inhibited by HM in a time-dependent manner (F=126.43,125.32,and 145.82 respectively,P＜0.01;F=147.95,222.67,and 242.28 respectively,P＜0.01).The IC50 of HM was 32.40μg/ml in PC12 cells treated with HM for 24 h,24.50μg/ml in cells treated for 48 h,and 15.37 μg/ml in cells treated for 72 h.The IC50 of HM was 62.19 μg/ml in NCTC1469 cells treated with HM for 24 h,38.43 μg/ml in cells treated for 48 h,and 28.52 μg/ml in cells treated for 72 h.In the control group,cells were anchored,they were arranged uniformly,they had basically the same size,they had distinct outlines,and there were few free-floating cells.In the experimental group,cells shrank and the number of cells and the growth density gradually decreased as the concentration of HM increased.Hoeehst33258 staining was used to observe different degrees of blue fluorescence of the nucleus after HM treatment for 24 h.Typical characteristics of apoptosis such as dense nuclei and strong staining were evident.The rate of apoptosis of PC12 cells was (12.52 ± 2.21) ％ after treatment with HM at a concentration of 10 ug/ml for 24 h,(23.44 ± 1.27) ％ after treatment with a concentration of 20 μg/ml,and (55.85±2.30)％ after treatment with a concentration of 40 μg/ml.The rate of apoptosis of NCTC1469 cells was (15.20±2.67)％ after treatment with HM at a concentration of 10 μg/ml for 24 h,(41.31±3.09) ％ after treatment with a concentration of 20μg/ml,and (53.92±2.58) ％ with a concentration of with a concentration of 40 μg/ml.The rates of apoptosis differed significantly from those in the control group (t=-27.42,-48.73,and-93.76,respectively,P＜0.01;t=-76.00,-116.67,and-144.25,respectively,P＜0.01).Conclusion HM markedly inhibited the proliferation and it promoted the apoptosis of PC12 and NCTC 1469 cells;this action occurred in a dose-dependent manner.

Harmine promotes megakaryocyte differentiation and thrombopoiesis by activating the Rac1/Cdc42/JNK pathway through a potential target of 5‐HTR2A

Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells.

Hirsutine, a novel megakaryopoiesis inducer, promotes thrombopoiesis via MEK/ERK/FOG1/TAL1 signaling

Homoharringtonine Exhibits Potent Anti-Tumor Effect and Modulates DNA Epigenome in Acute Myeloid Leukemia by Targeting SP1/TET1/5hmC.

Homoharringtonine Affects the Jak2-Stat5 Signal Pathway Through Alteration of Protein Tyrosine Kinase Phosphorylation in Acute Myeloid Leukemia Cells

Homoharringtonine Binds to and Increases Myosin-9 in Myeloid Leukaemia.

Homoharringtonine induces apoptosis and growth arrest in human myeloma cells.

Homoharringtonine mediates myeloid cell apoptosis via upregulation of pro-apoptotic bax and inducing caspase-3-mediated cleavage of poly(ADP-ribose) polymerase (PARP).

Hyperhomocysteinemia potentiates megakaryocyte differentiation and thrombopoiesis via GH-PI3K-Akt axis

Caulis Polygoni Multiflori Accelerates Megakaryopoiesis and Thrombopoiesis via Activating PI3K/Akt and MEK/ERK Signaling Pathways

MiR-370 Sensitizes Chronic Myeloid Leukemia K562 Cells to Homoharringtonine by Targeting Forkhead Box M1

Harmine Induces Anticancer Activity in Breast Cancer Cells Via Targeting TAZ

Harmine inhibits pulmonary fibrosis through regulating DNA damage repair-related genes and activation of TP53-Gadd45α pathway

Novel chemical-structure TPOR agonist, TMEA, promotes megakaryocytes differentiation and thrombopoiesis via mTOR and ERK signalings

Harmine Alleviates Atherogenesis by Inhibiting Disturbed Flow-Mediated Endothelial Activation Via Protein Tyrosine Phosphatase PTPN14 and YAP.

Harmine targets inhibitor of DNA binding‐2 and activator protein‐1 to promote preosteoclast PDGF‐BB production

Expansion of Human Megakaryocyte-Lineage Progeny Via Aryl Hydrocarbon Receptor Antagonism with CH223191

Effects of harmine on proliferation and apoptosis in PC12 and NCTC 1469 cells

Alnustone promotes megakaryocyte differentiation and platelet production via the interleukin-17A/interleukin-17A receptor/Src/RAC1/MEK/ERK signaling pathway

Homoharringtonine: a new treatment option for myeloid leukemia.

Harmine is an effective therapeutic small molecule for the treatment of cardiac hypertrophy